Loading
Algorae Pharmaceuticals Limited Stock: price and insider trades · Australia
Algorae Pharmaceuticals Limited: what insiders have been doing
Every trade that managers of Algorae Pharmaceuticals Limited disclose to ASX is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 3 filings came from 3 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 3 filings here.
Over the last twelve months, not one insider purchase of Algorae Pharmaceuticals Limited stock was filed.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.01
Analyst consensus
Income statement
EBITDA-A$2.2M
Net income-A$2.1M0.0% margin
Valuation
P/Book4.5x
Beta-0.07
Balance sheet & cash
Market capA$18.2M
Free Cash Flow-A$1.5M
Profitability & ownership
ROE-83.5%
ROA-41.9%
% insiders33.1%
% institutions0.0%
Last declaration on 30 September 2026
Declarations3 total
1 shares@ A$46,187.50100.0% of flowShareASXASX:2924-03142442-2A1700745
●
ShareASXISIN AU0000296022ASX:2924-03112881-2A1685319
ShareASXISIN AU0000296022ASX:2924-03112879-2A1685317
3 of 3 declarations
About Algorae Pharmaceuticals Limited
Algorae Pharmaceuticals Limited is a company listed on the XASX, focused on developing innovative pharmaceutical solutions.
